New molecule could reverse neurodegeneration in Parkinson’s

News

Author: Simge Eva DoganPublished: 11 October 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

molecule

Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.

The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.

The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.

They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.

Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Go Back

Share this story

Comments


Related articles


Portland Countdown Eli Pollard

Resources & Tools

World Parkinson Congress: “Nothing else like it anywhere”

Listen to this interview with Eli Pollard, director of the WPC

READ MORE
Dr Tilo Kunath and Ben Stecher lead

Perspectives

From diagnosis to clinical trial: my worldwide Parkinson’s journey

The PwP who’s visiting as many researchers as possible

READ MORE
Portland Countdown podcasts

Resources & Tools

Parkinson’s podcasts promise ‘new perspectives on latest science’

A new series of monthly Parkinson’s podcasts kicks off

READ MORE